Filing Flows › Bolt Biotherapeutics (BOLT) › Recalls, complaints & regulation
Bolt Biotherapeutics (BOLT): clinical trials
Bolt Biotherapeutics (BOLT) beyond its filings: 2 active clinical trials.
Bolt Biotherapeutics' latest quarter
Bolt Biotherapeutics, Q2 2026: revenue $5K (-100% year over year), net loss $7.7M, operating cash flow −$6.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Bolt Biotherapeutics have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.